A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment

NCT01939860 | Completed

• 1 other identifier: Warwick.123
• Study Type: interventional
• Target: 56
• Locations: 1 country
• Sites: 1

Brief Summary

Hypertension is a major health problem, however its control is unsatisfactory. One of the reasons for such a high prevalence of this disease includes poor patient compliance to treatment. Approximately 30 % of newly diagnosed hypertensive patients stop taking their blood pressure medication by six months and 50% by 12 months. The UK government is keen to encourage community pharmacists to play an active role in participation of services that can improve patient adherence to their medications. The New Medicines Service (NMS) and targeted Medicines Use Reviews (MUR) are established services which fund community pharmacists to review and explain medicine use to patients, with hypertension a common condition for which advice is given within these schemes. Within these schemes, advice is verbal and unstructured, with no specific written information provided on drugs or the disease being treated. This study aims to determine whether structured information provided to participants verbally and in writing by community pharmacists about blood pressure and current medicine(s) within NMS and targeted MURs will be retained and will be associated with improved hypertension control. Participants will be recruited from people eligible for NMS and MURs and attending community pharmacies.

Conditions

Hypertension

Outcome Measures

Primary Outcomes (1)

• Changes in systolic or diastolic blood pressure

  Systolic and diastolic blood pressure will be measured and recorded in mm Hg using OMRON blood pressure monitors

  1 year (trial would be stopped at 26 weeks if it is not possible to recruit any further participants

Secondary Outcomes (1)

• change in the knowledge of hypertension

  one year(trial would be stopped at 26 weeks if it is not possible to recruit any further participants)

Study Arms (2)

Usual pharmacy care

NO INTERVENTION

Participants will not receive any structured written education on hypertension and its treatment

usual pharmacy care plus structured information

EXPERIMENTAL

Participants will be provided with validated verbal and written information on hypertension and its treatment, including information about class (es) of anti-hypertensive medication(s) used by each patient, and their common side-effects. The written material will be based on validated patient information leaflets from the British Heart Foundation and the Blood Pressure Association.

Other: Written and verbal patient education on hypertension and its treatment

Interventions

Written and verbal patient education on hypertension and its treatment OTHER

usual pharmacy care plus structured information

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• )18 or over 2) male or female 3) Have been started on any blood pressure medication

You may not qualify if:

• )Patients with English language problems

Sponsors & Collaborators

• University of Warwick: lead

Study Sites (1)

J P Goes chemist

Coventry, United Kingdom

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD student

Study Record Dates

• First Submitted: September 3, 2013
• First Posted: September 11, 2013
• Study Start: January 1, 2014
• Primary Completion: June 1, 2014
• Study Completion: June 1, 2014
• Last Updated: December 5, 2017

Record last verified: 2017-12

Locations

GB (1)